Paul Rubin

Paul Rubin

Chief Tech/Sci/R&D Officer at BIOAGE LABS, INC.

Net worth: - $ as of 31/05/2026

72 year
Health Technology
Consumer Services

Profile

Paul D.
Rubin
is currently Chief Medical Officer & Executive VP-Research at BioAge Labs, Inc. since 2020.
Former positions include President & Chief Executive Officer at Critical Therapeutics, Inc. from 2002 to 2007; President & Chief Executive Officer at Resolvyx Pharmaceuticals, Inc. from 2007 to 2009; Vice President-Immunology & Endocrinology at Abbott Laboratories from 1987 to 1993; Executive Vice President-Research & Development at Sumitomo Pharma America, Inc. from 1996 to 2002; Chief Medical Officer, SVP-Research & Development at XOMA Royalty Corp.
from 2012 to 2016; Chief Medical Officer at Funxional Therapeutics Ltd. in 2011; Vice President-Worldwide Clinical Pharmacology at GlaxoSmithKline LLC from 1993 to 1996; Executive Vice President-Research & Development at Viridian Therapeutics, Inc. from 2017 to 2019; and Executive VP-Research & Development at Miragen, Inc. from 2016 to 2019.
Education includes undergraduate studies at Occidental College and a doctorate from Rush Medical College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/04/2026 0 ( -.--% ) - $ 31/05/2026

Paul Rubin active positions

CompaniesPositionStart
BIOAGE LABS, INC. Chief Tech/Sci/R&D Officer 01/05/2020

Former positions of Paul Rubin

CompaniesPositionEnd
VIRIDIAN THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 31/12/2019
Chief Tech/Sci/R&D Officer 01/12/2019
XOMA ROYALTY CORPORATION Chief Tech/Sci/R&D Officer 18/11/2016
Chief Tech/Sci/R&D Officer 01/06/2011
President 01/01/2009
See the detail of Paul Rubin's experience

Training of Paul Rubin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

53

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!